News | October 23, 2023
KKR to invest in life sciences firm Catalio Capital Management
Investment is additive to KKR’s existing health care growth strategy
Investment is additive to KKR’s existing health care growth strategy
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Eris Lifesciences enters into term loan agreement with Citi Bank
ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
